Deutsch
 
Hilfe Datenschutzhinweis Impressum
  DetailsucheBrowse

Datensatz

DATENSATZ AKTIONENEXPORT
  Oligonucleotide-protamine-albumin nanoparticles: preparation, physical properties, and intracellular distribution

Vogel, V., Lochmann, D., Weyermann, J., Mayer, G., Tziatzios, C., van den Broek, J. A., et al. (2005). Oligonucleotide-protamine-albumin nanoparticles: preparation, physical properties, and intracellular distribution. Journal of Controlled Release, 103(1), 99-111. doi:10.1016/j.jconrel.2004.11.029.

Item is

Basisdaten

einblenden: ausblenden:
Genre: Zeitschriftenartikel

Externe Referenzen

einblenden:

Urheber

einblenden:
ausblenden:
 Urheber:
Vogel, Vitali1, Autor
Lochmann, Dirk2, Autor
Weyermann, Jörg2, Autor
Mayer, Gottfried1, Autor
Tziatzios, Christos1, Autor
van den Broek, Jacomina A.1, Autor
Haase, Winfried3, Autor           
Wouters, Daan4, Autor
Schubert, Ulrich S.4, Autor
Kreuter, Jörg2, Autor
Zimmer, Andreas5, Autor
Schubert, Dieter1, Autor
Affiliations:
1Institut für Biophysik, Johann Wolfgang Goethe-Universität, 60590 Frankfurt am Main, Germany, ou_persistent22              
2Institut für Pharmazeutische Technologie, Johann Wolfgang Goethe-Universität, 60439 Frankfurt am Main, Germany, ou_persistent22              
3Department of Structural Biology, Max Planck Institute of Biophysics, Max Planck Society, ou_2068291              
4Laboratory of Macromolecular Chemistry and Nanoscience, Eindhoven University of Technology, NL-5600 MB Eindhoven, The Netherlands, ou_persistent22              
5Institut für Pharmazeutische Chemie und Pharmazeutische Technologie, Karl-Franzens-Universität, 8010 Graz, Austria, ou_persistent22              

Inhalt

einblenden:
ausblenden:
Schlagwörter: Nanoparticles; Phosphorothioates; Protamine; Human serum albumin (HSA); Cellular release
 Zusammenfassung: Oligodesoxynucleotides (ODNs) or the corresponding phosphorothioates (PTOs) spontaneously form spherical nanoparticles (“proticles”) with protamine in aqueous solutions. The proticles can cross cellular membranes and release the ODNs within the cells. Thus, they represent a potential drug delivery system. The major disadvantages of this system are a lack of stability in salt solutions and its inability to also release PTOs. The present study shows, using PTOs and protamine free base, that these shortcomings can be eliminated by the addition of human serum albumin (HSA) as a third component to the starting mixture. The “ternary” proticles thus obtained contain maximally a few percent of the HSA that was originally present. Nevertheless, they differ from the previously studied “binary” proticles: (1) They are stable in salt solutions for at least several hours. (2) They show a high cellular uptake into murine fibroblasts, and they readily release the PTOs after uptake. The ternary proticles therefore represent a considerable improvement over binary proticles for use as drug delivery systems.

Details

einblenden:
ausblenden:
Sprache(n): eng - English
 Datum: 2004-07-162004-11-222005-01-082005-03-02
 Publikationsstatus: Erschienen
 Seiten: 13
 Ort, Verlag, Ausgabe: -
 Inhaltsverzeichnis: -
 Art der Begutachtung: Expertenbegutachtung
 Identifikatoren: DOI: 10.1016/j.jconrel.2004.11.029
PMID: 15710504
 Art des Abschluß: -

Veranstaltung

einblenden:

Entscheidung

einblenden:

Projektinformation

einblenden:

Quelle 1

einblenden:
ausblenden:
Titel: Journal of Controlled Release
Genre der Quelle: Zeitschrift
 Urheber:
Affiliations:
Ort, Verlag, Ausgabe: Amsterdam : Elsevier
Seiten: - Band / Heft: 103 (1) Artikelnummer: - Start- / Endseite: 99 - 111 Identifikator: ISSN: 0168-3659
CoNE: https://pure.mpg.de/cone/journals/resource/954925484703